Screening and cellular validation of prognostic genes regulated by super enhancers in oral squamous cell carcinoma

References

• Haddad RI, Shin DM. Recent advances in head and neck cancer. N Engl J Med. 2008;359(11):1143–1154.
   PubMed Web of Science ®Google Scholar
• Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893–2917.
   PubMed Web of Science ®Google Scholar
• Wang HC, Chiang CJ, Liu TC, et al. Immunohistochemical expression of five protein combinations revealed as prognostic markers in Asian oral cancer. Front Genet. 2021;12:643461.
   PubMed Web of Science ®Google Scholar
• Cristaldi M, Mauceri R, Di Fede O, et al. Salivary biomarkers for oral squamous cell carcinoma diagnosis and follow-up: current status and perspectives. Front Physiol. 2019;10:1476.
   PubMed Web of Science ®Google Scholar
• Hashibe M, Brennan P, Chuang SC, et al. Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the international head and neck cancer epidemiology consortium. Cancer Epidemiol Biomarkers Prev. 2009;18(2):541–550.
   PubMed Web of Science ®Google Scholar
• Chow LQM, Longo DL. Head and neck cancer. N Engl J Med. 2020;382(1):60–72.
   PubMed Web of Science ®Google Scholar
• Kawakita D, Matsuo K. Alcohol and head and neck cancer. Cancer Metastasis Rev. 2017;36(3):425–434.
   PubMed Web of Science ®Google Scholar
• Lindemann A, Takahashi H, Patel AA, et al. Targeting the DNA damage response in OSCC with TP53 mutations. J Dent Res. 2018;97(6):635–644.
   PubMed Web of Science ®Google Scholar
• Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9(1):559.
   PubMed Web of Science ®Google Scholar
• Kakati T, Bhattacharyya DK, Barah P, et al. Comparison of methods for differential co-expression analysis for disease biomarker prediction. Comput Biol Med. 2019;113:103380.
   PubMed Web of Science ®Google Scholar
• Thandapani P. Super-enhancers in cancer. Pharmacol Ther. 2019;199:129–138.
   PubMed Web of Science ®Google Scholar
• Jia Q, Chen S, Tan Y, et al. Oncogenic super-enhancer formation in tumorigenesis and its molecular mechanisms. Exp Mol Med. 2020;52(5):713–723.
   PubMed Web of Science ®Google Scholar
• Sengupta S, George RE. Super-enhancer-driven transcriptional dependencies in cancer. Trends Cancer. 2017;3(4):269–281.
   PubMed Web of Science ®Google Scholar
• Loven J, Hoke HA, Lin CY, et al. Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell. 2013;153(2):320–334.
   PubMed Web of Science ®Google Scholar
• Hnisz D, Schuijers J, Lin CY, et al. Convergence of developmental and oncogenic signaling pathways at transcriptional super-enhancers. Mol Cell. 2015;58(2):362–370.
   PubMed Web of Science ®Google Scholar
• Tsompana M, Gluck C, Sethi I, et al. Reactivation of super-enhancers by KLF4 in human head and neck squamous cell carcinoma. Oncogene. 2020;39(2):262–277.
   PubMed Web of Science ®Google Scholar
• Zhang M, Hoyle RG, Ma Z, et al. FOSL1 promotes metastasis of head and neck squamous cell carcinoma through super-enhancer-driven transcription program. Mol Ther. 2021;29(8):2583–2600.
   Web of Science ®Google Scholar
• Zhang X, Choi PS, Francis JM, et al. Somatic superenhancer duplications and hotspot mutations lead to oncogenic activation of the KLF5 transcription factor. Cancer Discov. 2018;8(1):108–125.
   PubMed Web of Science ®Google Scholar
• Botia JA, Vandrovcova J, Forabosco P, et al. An additional k-means clustering step improves the biological features of WGCNA gene co-expression networks. BMC Syst Biol. 2017;11(1):47.
   PubMedGoogle Scholar
• Heinz S, Benner C, Spann N, et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell. 2010;38(4):576–589.
   PubMed Web of Science ®Google Scholar
• Whyte WA, Orlando DA, Hnisz D, et al. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell. 2013;153(2):307–319.
   PubMed Web of Science ®Google Scholar
• Zhang L, Xiong D, Liu Q, et al. Genome-wide histone H3K27 acetylation profiling identified genes correlated with prognosis in papillary thyroid carcinoma. Front Cell Dev Biol. 2021;9:682561.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zhou B, Pache L, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10(1):1523.
   PubMed Web of Science ®Google Scholar
• Zheng R, Wan C, Mei S, et al. Cistrome data browser: expanded datasets and new tools for gene regulatory analysis. Nucleic Acids Res. 2019;47(D1):D729–D735.
   PubMed Web of Science ®Google Scholar
• Otasek D, Morris JH, Boucas J, et al. Cytoscape automation: empowering workflow-based network analysis. Genome Biol. 2019;20(1):185.
   PubMed Web of Science ®Google Scholar
• Shannon P. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498–2504.
   PubMed Web of Science ®Google Scholar
• Ribeiro IP, Esteves L, Santos A, et al. A seven-gene signature to predict the prognosis of oral squamous cell carcinoma. Oncogene. 2021;40(22):3859–3869.
   PubMed Web of Science ®Google Scholar
• Kim TM, Huang W, Park R, et al. A developmental taxonomy of glioblastoma defined and maintained by MicroRNAs. Cancer Res. 2011;71(9):3387–3399.
   PubMed Web of Science ®Google Scholar
• Wang D, Gu J, Wang T, et al. OncomiRDB: a database for the experimentally verified oncogenic and tumor-suppressive microRNAs. Bioinformatics. 2014;30(15):2237–2238.
   PubMed Web of Science ®Google Scholar
• Rao X, Wan L, Jie Z, et al. Upregulated miR-27a-3p indicates a poor prognosis in pancreatic carcinoma patients and promotes the angiogenesis and migration by epigenetic silencing of GATA6 and activating VEGFA/VEGFR2 signaling pathway. Onco Targets Ther. 2019;12:11241–11254.
   PubMed Web of Science ®Google Scholar
• Refolo MG, Lotesoriere C, Lolli IR, et al. Molecular mechanisms of synergistic action of ramucirumab and paclitaxel in gastric cancers cell lines. Sci Rep. 2020;10(1):7162.
   PubMed Web of Science ®Google Scholar
• Zhao S, Guan X, Hou R, et al. Vitexin attenuates epithelial ovarian cancer cell viability and motility in vitro and carcinogenesis in vivo via p38 and ERK1/2 pathways related VEGFA. Ann Transl Med. 2020;8(18):1139.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Lu S, Li T, et al. ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa/VEGFR2/ERK pathway. J Exp Clin Cancer Res. 2019;38(1):173.
   PubMedGoogle Scholar
• Li CH, Sun XJ, Niu SS, et al. Overexpression of IQGAP1 promotes the angiogenesis of esophageal squamous cell carcinoma through the AKT and ERKmediated VEGFVEGFR2 signaling pathway. Oncol Rep. 2018;40(3):1795–1802.
   PubMed Web of Science ®Google Scholar
• Rubtsova SN, Zhitnyak IY, Gloushankova NA. Phenotypic plasticity of cancer cells based on remodeling of the actin cytoskeleton and adhesive structures. Int J Mol Sci. 2021;22(4):4.
   Web of Science ®Google Scholar
• Hnisz D, Abraham BJ, Lee TI, et al. Super-enhancers in the control of cell identity and disease. Cell. 2013;155(4):934–947.
   PubMed Web of Science ®Google Scholar
• Maxwell JH, Grandis JR, Ferris RL. HPV-associated head and neck cancer: unique features of epidemiology and clinical management. Annu Rev Med. 2016;67(1):91–101.
   PubMedGoogle Scholar
• Novak EM, Halley NS, Gimenez TM, et al. BLM germline and somatic PKMYT1 and AHCY mutations: genetic variations beyond MYCN and prognosis in neuroblastoma. Med Hypotheses. 2016;97:22–25.
   PubMed Web of Science ®Google Scholar
• Yin HR, Zhang L, Xie LQ, et al. Hyperplex-MRM: a hybrid multiple reaction monitoring method using mTRAQ/iTRAQ labeling for multiplex absolute quantification of human colorectal cancer biomarker. J Proteome Res. 2013;12(9):3912–3919.
   PubMed Web of Science ®Google Scholar
• Yoshimoto S, Loo TM, Atarashi K, et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature. 2013;499(7456):97–101.
   PubMed Web of Science ®Google Scholar
• Li Q, Mao L, Wang R, et al. Overexpression of S-adenosylhomocysteine hydrolase (SAHH) in esophageal squamous cell carcinoma (ESCC) cell lines: effects on apoptosis, migration and adhesion of cells. Mol Biol Rep. 2014;41(4):2409–2417.
   PubMed Web of Science ®Google Scholar
• Beilke S, Oswald F, Genze F, et al. The zinc-finger protein KCMF1 is overexpressed during pancreatic cancer development and downregulation of KCMF1 inhibits pancreatic cancer development in mice. Oncogene. 2010;29(28):4058–4067.
   PubMed Web of Science ®Google Scholar
• Sud N, Sharma R, Ray R, et al. Differential expression of beta mannosidase in human esophageal cancer. Int J Cancer. 2004;112(5):905–907.
   PubMed Web of Science ®Google Scholar
• Zhang J, Li H, Yabut O, et al. Cdk5 suppresses the neuronal cell cycle by disrupting the E2F1-DP1 complex. J Neurosci. 2010;30(15):5219–5228.
   PubMed Web of Science ®Google Scholar
• Morimoto Y, Mizushima T, Wu X, et al. miR-4711-5p regulates cancer stemness and cell cycle progression via KLF5, MDM2 and TFDP1 in colon cancer cells. Br J Cancer. 2020;122(7):1037–1049.
   PubMed Web of Science ®Google Scholar
• Zhan W, Wang W, Han T, et al. COMMD9 promotes TFDP1/E2F1 transcriptional activity via interaction with TFDP1 in non-small cell lung cancer. Cell Signal. 2017;30:59–66.
   PubMed Web of Science ®Google Scholar
• Lu X, Lv XD, Ren YH, et al. Dysregulation of TFDP1 and of the cell cycle pathway in high-grade glioblastoma multiforme: a bioinformatic analysis. Genet Mol Res. 2016;15(2):2.
   Web of Science ®Google Scholar